SOP-005 / SOP v2.0
Facility, cleaning and line clearance
Non-sterile compounding area and shared equipment.
Procedure
- Define receiving, quarantine, clean-material, compounding and finished-product zones. Arrange workflow to limit mix-ups and cross-contamination.
- Before each job remove materials, labels and documents from the previous batch. Record line-clearance verification.
- Use an approved cleaning procedure for each surface and residue. Define agent, concentration, contact time and rinsing from suitability evidence.
- Record scheduled and exceptional cleaning, operator, materials and outcome checks. Disinfection does not replace removal of chemical residues.
- For potent substances or allergens use specific residue controls and demonstrated cleaning suitability. Visual cleanliness is insufficient.
- Monitor temperature, humidity or other conditions where product quality depends on them. Record excursions and risk-appropriate waste management.
Edition-specific detail
Line clearance covers residual materials, previous labels/documents, clean equipment and the correct next formula. Record cleaner, concentration, contact time and final rinse. Visual cleanliness does not establish absence of potent drug or allergen; use SOP-022/F-015 when quantitative assessment is required.
Stop criterion
Residue, unknown previous material or undocumented cleaning: do not use the workstation.
Related forms
Sources and references
- NAPRA — Model Standards for Pharmacy Compounding of Non-sterile PreparationsMarch 2018, clarification January 2022Sections 4–9Risk, personnel, facilities and QA; its historical BUD table is not used for current USP defaults2026-09-12
- NAPRA — Guidance Document for Pharmacy Compounding of Non-sterile PreparationsMarch 2018, clarification January 2022Sections 5, 6 and 7; master/batch records, delivery, qualityQuality-system implementation; historical BUD table not substituted for 2022 USP revision2026-09-12
- PIC/S — Guide to Good Practices for the Preparation of Medicinal Products in Healthcare EstablishmentsPE 010-4, 1 March 2014Chapters 1–9; Annex 2 (nonsterile liquids, creams, ointments)Professional quality-system framework; not automatic national legal adoption or certification2026-09-12